Engineering bioactive mineralized tumor cells for tumor immunotherapy
IntroductionWhole-cell tumor vaccines are advantageous because of their ability to induce a broad and multifaceted immune response through the presentation of a wide range of tumor antigens, thereby enhancing the ability of the immune system to recognize and target cancerous cells.MethodIn this stud...
Saved in:
| Main Authors: | Zikun Shen, Yan He, Ren Mo, Dan Shao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Bioengineering and Biotechnology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2025.1582490/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The human STING agonist E7766 induces immunogenic tumor clearance, independent of tumor-intrinsic STING expression in the KRASG12D/+ Trp53−/− murine model of sarcoma
by: Karys M. Hildebrand, et al.
Published: (2025-12-01) -
Fragment Autoantigens Stimulated T‐Cell‐Immunotherapy (FAST) as a Fast Autologous Cancer Vaccine
by: Yuan Li, et al.
Published: (2025-07-01) -
Specific activation of cGAS-STING pathway by manganese-doped bioactive glasses for boosting systemic tumor immunotherapy
by: Zhaolin Yang, et al.
Published: (2025-04-01) -
Exploring the synergy between tumor microenvironment modulation and STING agonists in cancer immunotherapy
by: Xiaoyan Qi, et al.
Published: (2024-12-01) -
The STING-activating nanofactory relieves T cell exhaustion in Mn-based tumor immunotherapy by regulating mitochondrial dysfunction
by: Nana Chen, et al.
Published: (2025-05-01)